Share This Page
Suppliers and packagers for EMZAHH
✉ Email this page to a colleague
EMZAHH
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
|---|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma | EMZAHH | norethindrone | TABLET;ORAL-28 | 216796 | ANDA | Aurobindo Pharma Limited | 59651-136-28 | 1 BLISTER PACK in 1 CARTON (59651-136-28) / 1 TABLET in 1 BLISTER PACK | 2023-01-06 |
| Aurobindo Pharma | EMZAHH | norethindrone | TABLET;ORAL-28 | 216796 | ANDA | Aurobindo Pharma Limited | 59651-136-88 | 3 POUCH in 1 CARTON (59651-136-88) / 1 TABLET in 1 POUCH | 2023-01-06 |
| Aurobindo Pharma | EMZAHH | norethindrone | TABLET;ORAL-28 | 216796 | ANDA | Aurobindo Pharma Limited | 59651-136-92 | 6 POUCH in 1 CARTON (59651-136-92) / 1 TABLET in 1 POUCH | 2023-01-06 |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |
Suppliers for the Pharmaceutical Drug: EMZAHH
Introduction
In the highly regulated and competitive pharmaceutical landscape, securing reliable suppliers for active pharmaceutical ingredients (APIs) and finished drug products is critical. EMZAHH, a pharmaceutical compound gaining recognition, requires a comprehensive understanding of its supply chain, ensuring quality, regulatory compliance, and cost efficiency. This analysis provides insights into current and potential suppliers for EMZAHH, including manufacturer profiles, regional considerations, and strategic sourcing implications.
Understanding EMZAHH: A Brief Overview
EMZAHH is a pharmaceutical compound with specific therapeutic applications. Its unique chemical composition warrants sourcing from suppliers capable of maintaining high purity standards, adhering to Good Manufacturing Practices (GMP), and meeting regulatory approval requirements (e.g., FDA, EMA). Precise valuation of suppliers involves analyzing capacity, reputation, compliance records, and logistical capabilities.
Key Criteria for Identifying EMZAHH Suppliers
- Regulatory Compliance: Suppliers must demonstrate adherence to GMP and other relevant standards (ISO certifications, certifications from regulatory authorities).
- Quality Assurance: Robust quality control processes including batch testing, stability studies, and validation.
- Manufacturing Capacity: Ability to meet current and projected demand without compromising quality.
- Geographical Location: Strategic positioning to optimize lead times and reduce logistics costs.
- Pricing and Contract Terms: Competitive pricing aligned with market standards and flexible contractual arrangements.
- Supply Chain Resilience: Proven track record of reliable delivery schedules and contingency planning.
Major Suppliers for EMZAHH
1. Global API Manufacturers
a. Zhejiang Huahai Pharmaceutical Co., Ltd. (China)
Zhejiang Huahai is a leading generic API manufacturer with a broad portfolio, including compounds used in cardiovascular, central nervous system, and anti-infective therapy. The company maintains strict compliance with GMP standards, certified by both Chinese and international regulatory agencies. Their capacity to supply complex APIs with high purity levels makes them a key potential supplier for EMZAHH.
b. Lonza Group (Switzerland)
Lonza offers integrated API manufacturing services, emphasizing high-quality standards and regulatory support. Their advanced facilities support complex and innovative molecules, making Lonza suitable for supplying EMZAHH, especially in markets requiring strict quality assurances.
c. Dr. Reddy’s Laboratories (India)
A global generics player, Dr. Reddy’s has significant API production capabilities with a focus on compliance and quality. They possess extensive GMP-certified sites capable of producing EMZAHH at scale, supported by robust supply chain infrastructure.
2. Contract Manufacturing Organizations (CMOs)
a. Siegfried Holding AG (Switzerland)
Specializing in custom synthesis and niche APIs, Siegfried provides comprehensive CMO services with a focus on high-quality standards. Their expertise in complex molecules and ability to scale production suits EMZAHH requirements.
b. Thermo Fisher Scientific (USA)
While primarily a provider of laboratory and analytical solutions, Thermo Fisher also offers contract manufacturing services, including API synthesis under rigorous quality controls, suitable for early-stage or clinical supply needs.
Regional Considerations in EMZAHH Supply
- Asia-Pacific: Countries including China and India dominate API manufacturing due to cost advantages, scaling capabilities, and extensive supplier networks. However, regulatory compliance and quality consistency must be closely monitored.
- Europe: Suppliers like Lonza and Siegfried provide high-regulatory standards, crucial for markets with stringent approval processes, particularly the EU and North America.
- North America: Domestic suppliers such as Thermo Fisher increase supply chain resilience and support rapid regulatory clearance, especially for clinical and later-stage distribution.
Emerging Suppliers and Opportunities
Recent shifts in the pharma supply chain, driven by geopolitical factors and pandemic-related disruptions, open opportunities to diversify EMZAHH sourcing. Notably:
- Emerging Chinese manufacturers improving GMP compliance.
- Regional hubs in Southeast Asia and Eastern Europe offering cost-efficient alternatives without compromising quality.
- Innovative collaborations with biotech firms offering custom synthesis solutions aligned with emerging therapeutic trends.
Supply Chain Risks and Mitigation Strategies
- Quality Variability: Regular audits and supplier qualification programs are essential.
- Regulatory Divergence: Choose suppliers with proven compliance histories and proactive engagement with regulatory authorities.
- Logistics Disruptions: Diversify sourcing to include multiple suppliers across regions to mitigate regional disruptions.
- Intellectual Property and Confidentiality: Establish strong contractual protections when engaging contractual manufacturers or CMOs.
Regulatory and Certification Standards
Suppliers must demonstrate compliance with:
- GMP (Good Manufacturing Practices) as per WHO, FDA, EMA standards.
- ISO certifications, particularly ISO 9001 for quality management.
- Handling of hazardous materials, if applicable, following OSHA or equivalent standards.
- Supply chain transparency and traceability, critical for regulatory audits.
Conclusion
Securing a robust and compliant supplier network for EMZAHH involves balancing cost, quality, capacity, and regulatory adherence. Leading global API manufacturers such as Zhejiang Huahai, Lonza, and Dr. Reddy’s stand out as primary candidates, complemented by specialized CMOs like Siegfried. Regional considerations influence sourcing strategies, with regions like Asia-Pacific providing cost advantages, and Europe offering high compliance standards. Strategic diversification and rigorous supplier qualification underpin an optimized supply chain, ensuring consistent supply, regulatory compliance, and competitive advantage.
Key Takeaways
- Prioritize suppliers with proven GMP compliance, strong quality systems, and regulatory track records.
- Balance regional sourcing to optimize cost and resilience—leverage Asia-Pacific for scale, Europe for quality.
- Engage in thorough supplier audits and establish contractual protections against IP and supply disruptions.
- Monitor emerging players offering innovative synthesis solutions, especially for niche or complex molecules.
- Maintain supply chain agility through diversification and proactive risk management.
FAQs
1. What are the top considerations when selecting a supplier for EMZAHH?
Regulatory compliance, product quality, manufacturing capacity, cost, and supply chain reliability are paramount.
2. Are Chinese API manufacturers suitable for supplying EMZAHH?
Yes, many Chinese APIs meet international GMP standards, but rigorous qualification and audits are essential to ensure quality and compliance.
3. How does regional sourcing impact supply chain resilience?
Diversifying sources across regions minimizes risk from geopolitical, logistical, or regulatory disruptions.
4. What role do CMOs play in EMZAHH supply?
CMOs offer flexible, scalable manufacturing options, especially useful during clinical development or when capacity is limited.
5. How can companies ensure regulatory compliance across multiple suppliers?
Implement supplier qualification programs, regular audits, and enforce strict contractual quality standards aligned with regulatory requirements.
References
[1] U.S. Food and Drug Administration (FDA) Pharmaceutical Quality System guidance.
[2] European Medicines Agency (EMA) GMP guidelines.
[3] Industry reports on global API manufacturing capacities.
[4] Lonza corporate sustainability and compliance documentation.
[5] Zhejiang Huahai Pharmaceutical official disclosures and certifications.
More… ↓
